Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA warning letter
MedTech
Abbott hit by quality violations from FDA over CGM products
Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor franchise, FreeStyle Libre.
Ben Adams
Feb 4, 2026 9:25am
Dexcom receives FDA warning letter over manufacturing issues
Mar 10, 2025 11:53am
Applied CEO steps down in wake of FDA rejection, warning letter
Dec 20, 2024 12:51pm
Lawsuit alleges Applied misled investors before FDA rejection
Dec 19, 2024 7:34am
FDA chides Applied Therapeutics' trial conduct in warning letter
Dec 4, 2024 11:21am
UPDATE: Cue Health shuts down operations, lays off staff
May 22, 2024 2:15pm
